Your browser doesn't support javascript.
loading
Oncogenic dependency on ß-catenin in liver cancer cell lines correlates with pathway activation.
Ding, Zhihu; Shi, Chaomei; Jiang, Lan; Tolstykh, Tatiana; Cao, Hui; Bangari, Dinesh S; Ryan, Susan; Levit, Mikhail; Jin, Taiguang; Mamaat, Karl; Yu, Qunyan; Qu, Hui; Hopke, Joern; Cindhuchao, May; Hoffmann, Dietmar; Sun, Fangxian; Helms, Mike W; Jahn-Hofmann, Kerstin; Scheidler, Sabine; Schweizer, Liang; Fang, Douglas D; Pollard, Jack; Winter, Christopher; Wiederschain, Dmitri.
Afiliación
  • Ding Z; Sanofi Oncology Therapeutic Area, Cambridge, MA, USA.
  • Shi C; Sanofi Oncology Therapeutic Area, Cambridge, MA, USA.
  • Jiang L; Sanofi Oncology Therapeutic Area, Cambridge, MA, USA.
  • Tolstykh T; Sanofi Oncology Therapeutic Area, Cambridge, MA, USA.
  • Cao H; Sanofi Oncology Therapeutic Area, Cambridge, MA, USA.
  • Bangari DS; Sanofi Translational In Vivo Models, Framingham, MA, USA.
  • Ryan S; Sanofi Translational In Vivo Models, Framingham, MA, USA.
  • Levit M; Sanofi Translational Sciences, Cambridge, MA, USA.
  • Jin T; Sanofi Asia Pacific R&D Hub, Shanghai, People's Republic of China.
  • Mamaat K; Sanofi Oncology Therapeutic Area, Cambridge, MA, USA.
  • Yu Q; Current address: Leica Biosystems, Boston, MA.
  • Qu H; Sanofi Oncology Therapeutic Area, Cambridge, MA, USA.
  • Hopke J; Sanofi Oncology Therapeutic Area, Cambridge, MA, USA.
  • Cindhuchao M; Sanofi Biologics Research/Molecular Screening Technology, Cambridge, MA, USA.
  • Hoffmann D; Sanofi Biologics Research/Molecular Screening Technology, Cambridge, MA, USA.
  • Sun F; Sanofi Biologics Research/Molecular Screening Technology, Cambridge, MA, USA.
  • Helms MW; Sanofi Oncology Therapeutic Area, Cambridge, MA, USA.
  • Jahn-Hofmann K; Sanofi Biologics Research/Nucleic Acid Therapeutics, Frankfurt am Main, Germany.
  • Scheidler S; Sanofi Biologics Research/Nucleic Acid Therapeutics, Frankfurt am Main, Germany.
  • Schweizer L; Sanofi Biologics Research/Nucleic Acid Therapeutics, Frankfurt am Main, Germany.
  • Fang DD; Sanofi Asia Pacific R&D Hub, Shanghai, People's Republic of China.
  • Pollard J; Current address: Harbour BioMed, Shanghai, People's Republic of China.
  • Winter C; Discovery Services, WuXi AppTec Co., Shanghai, China.
  • Wiederschain D; Current address: Ascentage Pharma Group, Ltd., Suzhou, People's Republic of China.
Oncotarget ; 8(70): 114526-114539, 2017 Dec 29.
Article en En | MEDLINE | ID: mdl-29383099
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos